Azenta, Inc. (NASDAQ:AZTA) Short Interest Update

Azenta, Inc. (NASDAQ:AZTA - Get Free Report) was the recipient of a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 4,550,000 shares, an increase of 9.4% from the March 31st total of 4,160,000 shares. Approximately 8.3% of the shares of the company are sold short. Based on an average trading volume of 445,100 shares, the days-to-cover ratio is presently 10.2 days.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. Federated Hermes Inc. boosted its position in shares of Azenta by 29.2% during the 4th quarter. Federated Hermes Inc. now owns 365,506 shares of the company's stock valued at $23,809,000 after acquiring an additional 82,502 shares during the last quarter. Citigroup Inc. lifted its position in Azenta by 558.8% in the third quarter. Citigroup Inc. now owns 88,078 shares of the company's stock worth $4,421,000 after buying an additional 74,708 shares during the last quarter. Millrace Asset Group Inc. bought a new stake in Azenta in the third quarter worth $1,074,000. Trexquant Investment LP bought a new stake in Azenta in the third quarter worth $860,000. Finally, Invesco Ltd. lifted its position in Azenta by 35.4% in the third quarter. Invesco Ltd. now owns 331,012 shares of the company's stock worth $16,613,000 after buying an additional 86,477 shares during the last quarter. 99.08% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

AZTA has been the topic of a number of recent analyst reports. Jefferies Financial Group started coverage on shares of Azenta in a report on Thursday, April 4th. They set a "hold" rating and a $64.00 price target on the stock. Needham & Company LLC reiterated a "buy" rating and set a $75.00 price target on shares of Azenta in a research note on Monday, April 8th. Stephens reiterated an "equal weight" rating and set a $70.00 target price on shares of Azenta in a research report on Thursday, February 8th. Evercore ISI reduced their price target on Azenta from $64.00 to $60.00 and set an "in-line" rating for the company in a research report on Thursday, April 4th. Finally, B. Riley lifted their price objective on Azenta from $61.00 to $79.00 and gave the company a "buy" rating in a research report on Thursday, February 1st. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $69.60.

Azenta Trading Down 1.4 %

Azenta stock traded down $0.75 during midday trading on Tuesday, hitting $52.46. The stock had a trading volume of 324,122 shares, compared to its average volume of 424,229. Azenta has a 52-week low of $36.01 and a 52-week high of $69.16. The firm's fifty day moving average is $59.16 and its two-hundred day moving average is $59.12. The company has a market capitalization of $2.93 billion, a PE ratio of -169.22 and a beta of 1.53.

Azenta (NASDAQ:AZTA - Get Free Report) last announced its quarterly earnings data on Wednesday, February 7th. The company reported $0.02 earnings per share (EPS) for the quarter. Azenta had a negative net margin of 2.92% and a positive return on equity of 0.49%. The business had revenue of $154.32 million during the quarter, compared to analyst estimates of $151.86 million. As a group, equities research analysts predict that Azenta will post 0.27 earnings per share for the current fiscal year.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.